Update
$UNCY.US$ Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings From Pivotal Clinical Trial Of Oxylanthanum Carbonate (OLC) - Company Says Patients Preferred OLC More Than 4 To 1 Over Prior Phosphate Binder Therapy
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
